Head of Clinical Development
Owkin, United Kingdom
Dr Luke Kuttschreuter MBChB FFPM is a board-certified specialist pharmaceurical physician, based in the UK, and is currently the Head of Clinical Development for the TechBio company, Owkin, which uses traditional drug development approach enhanced by cutting-edge artifical intelligence. Dr Kuttschreuter has experience in development of novel small molecules and biologics across multiple oncology indications, including several studies in soft tissue sarcoma subtypes.
The presentation of the INVOKE clinical trial at CTOS 2025 will be done by one of the study investigators, Kalmesh Kumar Sankhala, MD.